Dr. Stein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8635 W 3rd St
Ste 865W
Los Angeles, CA 90048Phone+1 310-854-1904Fax+1 310-427-6763
Education & Training
- Good Samaritan HospitalFellowship, Thoracic Surgery, 1979 - 1981
- Mount Sinai Medical Center of FloridaResidency, Surgery, 1976 - 1979
- Beth Israel Deaconess Medical CenterFellowship, Thoracic Surgery, 1975 - 1976
- Charing Cross and Westminister Medical SchoolClass of 1973
Certifications & Licensure
- DE State Medical License Current
- AR State Medical License 2021 - 2026
- WA State Medical License 2019 - 2026
- TN State Medical License 2023 - 2026
- NE State Medical License 2023 - 2026
- ND State Medical License 2024 - 2026
- MI State Medical License 2023 - 2026
- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
- Join now to see all
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- A 51-Year-Old Man With Recurrent Bacteremia and Acute Neurologic Symptoms After Being Treated for Presumptive EndocarditisDavid Lalezari, Jasminka M. Criley, Nikhil Kapoor, Chester Choi, Alexander Stein
Chest. 2013-01-01 - 3 citationsClinical patterns of surgical endocarditis.Fritz J. Baumgartner, Jeffrey C. Milliken, John M. Robertson, Alexander G. Stein, Rosalyn P. Scott
Journal of Cardiac Surgery. 2007-01-01
Lectures
- Avelumab and cetuximab in combination with FOLFOX in patients with previously untreated metastatic colorectal cancer (MCRC): Final results of the phase II AVETUX trial...ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020
- Avelumab and cetuximab in combination with FOLFOX in patients with previously untreated metastatic colorectal cancer (MCRC): Results of the safety run-in phase of the ...2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
Press Mentions
- Adding Opdivo in First-Line Shows Promise in HER2+ Esophagogastric CancerJune 23rd, 2022
- The Unintended Consequences of Outsourcing Human Issues to Technological SurrogatesSeptember 19th, 2017
- Morning Report: Why COVID-19 Has Hit Latinos so HardAugust 14th, 2020
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: